Cargando…

Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease

Neuroinflammation plays an important role in the pathophysiology of Alzheimer’s disease. The cannabinoid type 2 receptor (CB(2)R) is an emerging target for neuroinflammation and therapeutics of Alzheimer’s disease. Here, we aim to assess the alterations in brain CB(2)R levels and evaluate novel CB(2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kecheliev, Vasil, Spinelli, Francesco, Herde, Adrienne, Haider, Ahmed, Mu, Linjing, Klohs, Jan, Ametamey, Simon M., Ni, Ruiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561934/ https://www.ncbi.nlm.nih.gov/pubmed/36248003 http://dx.doi.org/10.3389/fnagi.2022.1018610

Ejemplares similares

In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI
por: Ni, Ruiqing, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging
por: Haider, Ahmed, et al.
Publicado: (2016)

Extracerebral Tissue Damage in the Intraluminal Filament Mouse Model of Middle Cerebral Artery Occlusion
por: Vaas, Markus, et al.
Publicado: (2017)

Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer’s disease
por: Ni, Ruiqing, et al.
Publicado: (2018)

Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion
por: Ni, Ruiqing, et al.
Publicado: (2023)

Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
por: Mu, Linjing, et al.
Publicado: (2014)

Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [(18)F]PSS232 in the Rat Brain
por: Müller Herde, Adrienne, et al.
Publicado: (2018)

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
por: Bao, Weiqi, et al.
Publicado: (2021)

Structural MRI Reveals Cervical Spinal Cord Atrophy in the P301L Mouse Model of Tauopathy: Gender and Transgene-Dosing Effects
por: Sartoretti, Thomas, et al.
Publicado: (2022)

fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis
por: Ni, Ruiqing, et al.
Publicado: (2019)

Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
por: Klohs, Jan, et al.
Publicado: (2014)

Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
por: Colom, Matthieu, et al.
Publicado: (2019)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Improved Syntheses of the mGlu(5) Antagonists MMPEP and MTEP Using Sonogashira Cross-Coupling
por: Mu, Boshuai, et al.
Publicado: (2018)

Multi-scale optoacoustic molecular imaging of brain diseases
por: Razansky, Daniel, et al.
Publicado: (2021)

Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy
por: Kindler, Diana, et al.
Publicado: (2021)

Impact of the Cannabinoid System in Alzheimer's Disease
por: Li, Shuangtao, et al.
Publicado: (2023)

Quantification of the Cannabinoid Type 1 Receptor Availability in the Mouse Brain
por: Miederer, Isabelle, et al.
Publicado: (2020)

Rhenium(i) complexation–dissociation strategy for synthesising fluorine-18 labelled pyridine bidentate radiotracers
por: Klenner, Mitchell A., et al.
Publicado: (2020)

Cannabinoid-dependent potentiation of inhibition at eye opening in mouse V1
por: Garkun, Yury, et al.
Publicado: (2014)

Cannabinoids Modulate Light Signaling in ON-Sustained Retinal Ganglion Cells of the Mouse
por: Middleton, Terence Peter, et al.
Publicado: (2019)

Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use
por: Shaw, Robert C., et al.
Publicado: (2020)

Toward Novel [(18)F]Fluorine-Labeled Radiotracers for the Imaging of α-Synuclein Fibrils
por: Uzuegbunam, Bright C., et al.
Publicado: (2022)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Cannabinoids, Endocannabinoids and Sleep
por: Kesner, Andrew J., et al.
Publicado: (2020)

[(11)C]mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [(18)F]LMI1195 uptake is NET-independent
por: Mu, Linjing, et al.
Publicado: (2020)

Magnetic Resonance Q Mapping Reveals a Decrease in Microvessel Density in the arcAβ Mouse Model of Cerebral Amyloidosis
por: Ielacqua, Giovanna D., et al.
Publicado: (2016)

Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments
por: Satta, Valentina, et al.
Publicado: (2021)

Basic physics of radiotracers
por: Barnes, W Earl
Publicado: (2017)

Cannabinoid Modulation of the Stressed Hippocampus
por: Scarante, Franciele F., et al.
Publicado: (2017)

Crystallographic study of PET radiotracers in clinical evaluation for early diagnosis of Alzheimers
por: Altomare, Angela, et al.
Publicado: (2014)

Cannabinoid CB(2) receptors in the mouse brain: relevance for Alzheimer’s disease
por: López, Alicia, et al.
Publicado: (2018)

Electroacupuncture Potentiates Cannabinoid Receptor-Mediated Descending Inhibitory Control in a Mouse Model of Knee Osteoarthritis
por: Yuan, Xiao-Cui, et al.
Publicado: (2018)

NPAS4 recruits CCK basket cell synapses and enhances cannabinoid-sensitive inhibition in the mouse hippocampus
por: Hartzell, Andrea L, et al.
Publicado: (2018)

Magnetic Resonance Imaging in Tauopathy Animal Models
por: Ni, Ruiqing
Publicado: (2022)

SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy
por: Ni, Ruiqing, et al.
Publicado: (2020)

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
por: Navarro-Dorado, Jorge, et al.
Publicado: (2016)

Broad and Region-Specific Impacts of the Synthetic Cannabinoid CP 55,940 in Adolescent and Adult Female Mouse Brains
por: Leishman, Emma, et al.
Publicado: (2018)

The Neuroglial Dialog Between Cannabinoids and Hemichannels
por: Labra, Valeria C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ej43vvk6embd8g3j41ir8a1fr3